Irinotecan-containing doublet treatment versus irinotecan monotherapy as second-line choice for advanced gastric cancer

Abstract Background For patients with advanced gastric cancer (AGC), second-line chemotherapy regimen remains controversial. The efficacy and safety of irinotecan-containing doublet treatment and irinotecan monotherapy were compared in this systematic analysis. Methods A search was conducted on EMBA...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Liuting Yang, Xiaoyue Jiang, Han Yan, Yingying Li, Hongchao Zhen, Bingmei Chang, Seyed Kariminia, Qin Li
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	BMC 2018-04-01
Schriftenreihe:	BMC Gastroenterology
Schlagworte:	Irinotecan Second-line chemotherapy Advanced gastric cancer Efficacy Safety
Online-Zugang:	http://link.springer.com/article/10.1186/s12876-018-0772-4
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!